136 related articles for article (PubMed ID: 9226155)
1. Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines.
König A; Wrazel L; Warrell RP; Rivi R; Pandolfi PP; Jakubowski A; Gabrilove JL
Blood; 1997 Jul; 90(2):562-70. PubMed ID: 9226155
[TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients.
Rousselot P; Labaume S; Marolleau JP; Larghero J; Noguera MH; Brouet JC; Fermand JP
Cancer Res; 1999 Mar; 59(5):1041-8. PubMed ID: 10070961
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner.
Wang ZG; Rivi R; Delva L; König A; Scheinberg DA; Gambacorti-Passerini C; Gabrilove JL; Warrell RP; Pandolfi PP
Blood; 1998 Sep; 92(5):1497-504. PubMed ID: 9716575
[TBL] [Abstract][Full Text] [Related]
4. The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms.
Zhang W; Ohnishi K; Shigeno K; Fujisawa S; Naito K; Nakamura S; Takeshita K; Takeshita A; Ohno R
Leukemia; 1998 Sep; 12(9):1383-91. PubMed ID: 9737686
[TBL] [Abstract][Full Text] [Related]
5. Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis.
König A; Menzel T; Lynen S; Wrazel L; Rosén A; Al-Katib A; Raveche E; Gabrilove JL
Leukemia; 1997 Feb; 11(2):258-65. PubMed ID: 9009090
[TBL] [Abstract][Full Text] [Related]
6. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells.
Chen GQ; Shi XG; Tang W; Xiong SM; Zhu J; Cai X; Han ZG; Ni JH; Shi GY; Jia PM; Liu MM; He KL; Niu C; Ma J; Zhang P; Zhang TD; Paul P; Naoe T; Kitamura K; Miller W; Waxman S; Wang ZY; de The H; Chen SJ; Chen Z
Blood; 1997 May; 89(9):3345-53. PubMed ID: 9129041
[TBL] [Abstract][Full Text] [Related]
7. Effect of arsenic trioxide on viability, proliferation, and apoptosis in human megakaryocytic leukemia cell lines.
Lu M; Levin J; Sulpice E; Sequeira-Le Grand A; Alemany M; Caen JP; Han ZC
Exp Hematol; 1999 May; 27(5):845-52. PubMed ID: 10340400
[TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide induces apoptosis in B-cell chronic lymphocytic leukemic cells through down-regulation of survivin via the p53-dependent signaling pathway.
Zhang XH; Feng R; Lv M; Jiang Q; Zhu HH; Qing YZ; Bao JL; Huang XJ; Zheng XL
Leuk Res; 2013 Dec; 37(12):1719-25. PubMed ID: 24211095
[TBL] [Abstract][Full Text] [Related]
9. The novel cyclin-dependent kinase inhibitor flavopiridol downregulates Bcl-2 and induces growth arrest and apoptosis in chronic B-cell leukemia lines.
König A; Schwartz GK; Mohammad RM; Al-Katib A; Gabrilove JL
Blood; 1997 Dec; 90(11):4307-12. PubMed ID: 9373241
[TBL] [Abstract][Full Text] [Related]
10. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins.
Chen GQ; Zhu J; Shi XG; Ni JH; Zhong HJ; Si GY; Jin XL; Tang W; Li XS; Xong SM; Shen ZX; Sun GL; Ma J; Zhang P; Zhang TD; Gazin C; Naoe T; Chen SJ; Wang ZY; Chen Z
Blood; 1996 Aug; 88(3):1052-61. PubMed ID: 8704214
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide (As2O3)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice.
Kinjo K; Kizaki M; Muto A; Fukuchi Y; Umezawa A; Yamato K; Nishihara T; Hata J; Ito M; Ueyama Y; Ikeda Y
Leukemia; 2000 Mar; 14(3):431-8. PubMed ID: 10720138
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
Zhu XH; Shen YL; Jing YK; Cai X; Jia PM; Huang Y; Tang W; Shi GY; Sun YP; Dai J; Wang ZY; Chen SJ; Zhang TD; Waxman S; Chen Z; Chen GQ
J Natl Cancer Inst; 1999 May; 91(9):772-8. PubMed ID: 10328107
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide causes redistribution of cell cycle, caspase activation, and GADD expression in human colonic, breast, and pancreatic cancer cells.
Li X; Ding X; Adrian TE
Cancer Invest; 2004; 22(3):389-400. PubMed ID: 15493360
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide and the growth of human T-cell leukemia virus type I infected T-cell lines.
Ishitsuka K; Hanada S; Uozumi K; Utsunomiya A; Arima T
Leuk Lymphoma; 2000 May; 37(5-6):649-55. PubMed ID: 11042529
[TBL] [Abstract][Full Text] [Related]
15. Arsenic compounds induce cytotoxicity and apoptosis in cisplatin-sensitive and -resistant gynecological cancer cell lines.
Du YH; Ho PC
Cancer Chemother Pharmacol; 2001 Jun; 47(6):481-90. PubMed ID: 11459200
[TBL] [Abstract][Full Text] [Related]
16. Phenylarsine oxide (PAO) more intensely induces apoptosis in acute promyelocytic leukemia and As2O3-resistant APL cell lines than As2O3 by activating the mitochondrial pathway.
Sahara N; Takeshita A; Kobayashi M; Shigeno K; Nakamura S; Shinjo K; Naito K; Maekawa M; Horii T; Ohnishi K; Kitamura K; Naoe T; Hayash H; Ohno R
Leuk Lymphoma; 2004 May; 45(5):987-95. PubMed ID: 15291359
[TBL] [Abstract][Full Text] [Related]
17. Arsenic-induced apoptosis in malignant cells in vitro.
Akao Y; Yamada H; Nakagawa Y
Leuk Lymphoma; 2000 Mar; 37(1-2):53-63. PubMed ID: 10721769
[TBL] [Abstract][Full Text] [Related]
18. Morphological and biochemical changes induced by arsenic trioxide in neuroblastoma cell lines.
Ryu KH; Woo SY; Lee MY; Jung YJ; Yoo ES; Seoh JY; Kie JH; Shin HY; Ahn HS
Pediatr Hematol Oncol; 2005; 22(7):609-21. PubMed ID: 16166054
[TBL] [Abstract][Full Text] [Related]
19. The effects of arsenic trioxide (As2O3) on human megakaryocytic leukemia cell lines. With a comparison of its effects on other cell lineages.
Alemany M; Levin J
Leuk Lymphoma; 2000 Jun; 38(1-2):153-63. PubMed ID: 10811458
[TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide induces apoptosis preferentially in B-CLL cells of patients with unfavourable prognostic factors including del17p13.
Merkel O; Heyder C; Asslaber D; Hamacher F; Tinhofer I; Holler C; Stöcher M; Prokesch A; Papak C; Scheideler M; Trajanoski Z; Greil R
J Mol Med (Berl); 2008 May; 86(5):541-52. PubMed ID: 18297255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]